Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events.
Department of Pharmacology and Toxicology, Research Unit of Biomedicine, University of Oulu, Finland (R.K., J.U., J.M.) Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Finland (R.K.).
Risto
R
Kerkelä
Department of Pharmacology and Toxicology, Research Unit of Biomedicine, University of Oulu, Finland (R.K., J.U., J.M.).
Johanna
J
Ulvila
Department of Pharmacology and Toxicology, Research Unit of Biomedicine, University of Oulu, Finland (R.K., J.U., J.M.).
Johanna
J
Magga
D000818:Animals; D003920:Diabetes Mellitus / Q000378:metabolism; D004734:Energy Metabolism / Q000187:drug effects; D005786:Gene Expression Regulation; D006331:Heart Diseases / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D024821:Metabolic Syndrome / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D045265:Natriuretic Peptides / Q000235:genetics / Q000378:metabolism* / Q000627:therapeutic use; D017461:Receptors, Atrial Natriuretic Factor / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects
D045265:Natriuretic Peptides; D017461:Receptors, Atrial Natriuretic Factor
cardiac hypertrophy; fibrosis; heart failure; metabolism; natriuretic peptides